impact of dapagliflozin on left ventricular diastolic function in diabetic patients with heart failure complicating cardiovascular risk factors

Fumitaka Soga,Hidekazu Tanaka,Kazuhiro Tatsumi,Yasuhide Mochizuki,Hiroyuki Sano,Hiromi Toki,Kensuke Matsumoto,Junya Shite,Hideyuki Takaoka,Tomofumi Doi,Ken-ichi Hirata

impact of dapagliflozin on left ventricular diastolic function in diabetic patients with heart failure complicating cardiovascular risk factors

2021

Fumitaka Soga
Hidekazu Tanaka
Kazuhiro Tatsumi
Yasuhide Mochizuki
Hiroyuki Sano
Hiromi Toki
Kensuke Matsumoto
Junya Shite
Hideyuki Takaoka
Tomofumi Doi
Ken-ichi Hirata

Our aim was to investigate the impact of sodium glucose cotransporter type 2 (SGLT2) inhibitor on left ventricular (LV) diastolic function in type 2 diabetes mellitus (T2DM) patients with heart failure (HF) complicating cardiovascular risk factors. We analyzed data from our previous prospective

Keywords:

Medicine
cardiovascular risk factors
Heart failure
Dapagliflozin
Cardiology
Internal medicine
Diastolic function

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations